Latest Targeted therapy Stories
TAMPA, Fla., March 12, 2015 /PRNewswire/ -- Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc.
Close competition encourages established manufacturers to broaden the drug pipeline for targeted therapies, finds Frost & Sullivan LONDON, March 3, 2015 /PRNewswire/ -- Although lung
Epic's circulating tumor cell analysis provides comprehensive, real-time information from a liquid biopsy that could help guide cancer treatments SAN DIEGO, Feb.
Research Presented at 2015 Genitourinary Cancers Symposium Highlights Clinical Utility of Caris Molecular Intelligence in Identifying Potential Treatment Strategies for Challenging Genitourinary Cancers
Circulating tumor cell analysis provides comprehensive information from a real-time liquid biopsy that could help guide treatments for metastatic prostate cancers and bladder cancers SAN
SEATTLE, Feb. 3, 2015 /PRNewswire/ -- CTI BioPharma Corp.
SAN DIEGO, Jan.
Novel Diagnostic Helping Answer U.S. President's Call for Action on Precision Medicine Initiative JERUSALEM, Jan.
Second Orphan Designation for OncoSynergy's Novel Multi-Indication Platform Drug SAN FRANCISCO, Jan.
Prospective clinical studies to evaluate Trovagene's Precision Cancer Monitoring platform to determine the emergence of resistance mutations using circulating tumor DNA SAN DIEGO,
- A person in a secondary role, specifically the second most important character (after the protagonist).